Skip to main content
Skip to section navigation
Skip to footer
ViraxImmune™
Products
Services
Media
Leadership
Contact Us
Investor Relations
Menu
ViraxImmune™
Products
Services
Media
Leadership
Contact Us
Investor Relations
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Financial Results
2025
FY 2025
Fiscal Year Ended Mar 31, 2025
20-F
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
2024
FY 2024
Fiscal Year Ended Mar 31, 2024
20-F
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
2023
FY 2023
Fiscal Year Ended Mar 31, 2023
20-F
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
2022
FY 2022
Fiscal Year Ended Mar 31, 2022
20-F
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Email Alerts
Contacts
RSS News Feed
